Infinimmune vs Ray Therapeutics
Infinimmune vs Ray Therapeutics, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Infinimmune is on 60/100 and Ray Therapeutics on 53/100.
Where each one leads
Infinimmune
- our overall score: 60/100 against 53/100
- agent readiness: 42/100 against 21/100
Ray Therapeutics
- domain rating: 29/100 against 20/100
- funding raised: $243M against $75.0M
At a glance
| Measure | Infinimmune | Ray Therapeutics |
|---|---|---|
| What it is | Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms. | Pioneering vision restoration therapies for severe retinal degenerations. |
| Category | Biotechnology, Pharmaceuticals, Artificial Intelligence, HealthTech | Biotechnology, Pharmaceuticals, Healthcare, Medical Devices |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2017 | 2021 |
| Headquarters | Alameda, United States | Berkeley, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Infinimmune | Ray Therapeutics |
|---|---|---|
| Employees | 22 | Not published |
| Total funding | $75.0M | $243M |
| Latest round | Series A | Series B |
| LinkedIn followers | 4,055 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Infinimmune | Ray Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 60/100 | 53/100 |
| Traction | 53/100 | 40/100 |
| Team | 70/100 | 50/100 |
| Search visibility | 23/100 | 14/100 |
| Quality | 68/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (42/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 20/100 | 29/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Infinimmune | Ray Therapeutics |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | Webflow | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Google Analytics 4 | Google Analytics 4 |
Infinimmune vs Ray Therapeutics: common questions
Which is better, Infinimmune or Ray Therapeutics?
On our 0-100 score Infinimmune rates higher (60/100 against 53/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Infinimmune and Ray Therapeutics compare on the numbers?
Infinimmune leads on our overall score (60/100 against 53/100), agent readiness (42/100 against 21/100). Ray Therapeutics leads on domain rating (29/100 against 20/100), funding raised ($243M against $75.0M).
Read the full Infinimmune review and pricing or the Ray Therapeutics review and pricing. You can also browse other Infinimmune alternatives we track.